Smartest Doc
Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barretts esophagus radiofrequency ablation treatment response
Gastrointestinal Endoscopy, 07/31/2012
Clinical Article
Tsai TH et al. – Three–dimensional optical coherence tomography (OCT) assessment of Barrett's esophagus (BE) thickness and residual glands during Radiofrequency ablation (RFA) sessions correlated with treatment response. Three–dimensional OCT may predict responses to RFA or aid in making real–time RFA retreatment decisions in the future.
Methods- Thirty-three patients, 32 male and 1 female, with short-segment (<3 cm) BE undergoing RFA treatment.
- Patients were treated with focal RFA, and 3-D OCT was performed at the gastroesophageal junction before and immediately after the RFA treatment.
- Patients were re-examined with standard endoscopy 6 to 8 weeks later and had biopsies to rule out BE if not visibly evident.
- The thickness of BE epithelium before RFA and the presence of residual gland-like structures immediately after RFA were determined by using 3-D OCT.
- The presence of BE at follow-up was assessed endoscopically.
- BE mucosa was significantly thinner in patients who achieved complete eradication of intestinal metaplasia than in patients who did not achieve complete eradication of intestinal metaplasia at follow-up (257 ± 60 μm vs 403 ± 86 μm; P<.0001).
- A threshold thickness of 333 μm derived from receiver operating characteristic curves corresponded to a 92.3% sensitivity, 85% specificity, and 87.9% accuracy in predicting the presence of BE at follow-up.
- The presence of OCT-visible glands immediately after RFA also correlated with the presence of residual BE at follow-up (83.3% sensitivity, 95% specificity, 90.6% accuracy).